Beta-catenin regulates myogenesis by relieving I-mfa-mediated suppression of myogenic regulatory factors in P19 cells
Although we made significant efforts to conduct a comprehensive search and minimize publication biases, it is essential to acknowledge that some biases may still exist
Troglitazone has several recognized therapeutic properties as a hypoglycemic agent, an antioxidant, a vasodilator agent, an anticonvulsant, an anticoagulant, a platelet aggregation inhibitor, an antineoplastic agent, an EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor and a ferroptosis inhibitor (National Center for Biotechnology Information, 2023h)
Its power to restore youthful gene expression patterns, enhance cellular function, promote tissue repair, and produce visible gains in aging markers makes it one of the most valuable tools available for anti-aging research